IP Library Granted Patent US 11,065,400
Granted Patent B2
US 11,065,400 · App. 15/633,508 · Granted Jul 20, 2021

Aerosol forming device for use in inhalation therapy

Inventors: Craig C. Hodges (Walnut Creek, CA); Peter M. Lloyd (Walnut Creek, CA); Daniel Mufson (Napa, CA); Daniel D. Rogers (Oakland, CA); Martin J. Wensley (Los Gatos, CA)
Assignee: ALEXZA PHARMACEUTICALS, INC.
A61M11/044A61K9/007A61K9/0073A61K31/235A61K31/4468A61K31/485A61K31/519A61M11/001A61M11/02A61M15/00A61M15/0028A61M16/109B05B7/1686B05B17/04A61M2016/0039A61M2205/3606A61M2205/368A61M2205/3653A61M2205/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,065,400
App. No.
15/633,508
Granted
Jul 20, 2021
Kind
B2
Abstract

Inhalation delivery of aerosols containing small particles is described. Specifically, it relates to a device that forms drug containing aerosols for use in inhalation therapy. In a device aspect of the present disclosure, a device for delivering drug containing aerosols for inhalation therapy is provided. The device includes a housing and an airway that has a gas/vapor mixing airway. The airway further includes a subassembly, which has a metallic substrate coated on its surface with a composition comprising a drug.

Claims (2)

1. A device for delivering apomorphine containing aerosols including: a housing; and, an airway including a gas/vapor mixing area, wherein the airway includes a subassembly, and wherein the subassembly includes a metallic substrate, and wherein a composition comprising apomorphine is coated on the substrate.

2. A device for delivering fentanyl containing aerosols including: a housing; and, an airway including a gas/vapor mixing area, wherein the airway includes a subassembly, and wherein the subassembly includes a metallic substrate, and wherein a composition comprising fentanyl is coated on the substrate.

Assignments (3)
CHANGE OF NAME Recorded Jul 20, 2017
From: ALEXZA MOLECULAR DELIVERY CORPORATION
To: ALEXZA PHARMACEUTICALS, INC.
Reel/Frame 043280/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2017
From: HODGES, CRAIG C.; LLOYD, PETER M.; MUFSON, DANIEL; ROGERS, DANIEL D.; WENSLEY, MARTIN J.
To: ALEXZA MOLECULAR DELIVERY CORPORATION
Reel/Frame 043001/0871 →
CHANGE OF NAME Recorded Jul 13, 2017
From: ALEXZA MOLECULAR DELIVERY CORPORATION
To: ALEXZA PHARMACEUTICALS, INC.
Reel/Frame 043187/0098 →